Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
Susan M. Bueno, Katia Abarca, Pablo A. González, Nicolás M.S. Gálvez, Jorge A. Soto, Luisa F. Duarte, Bárbara M. Schultz, Gaspar A. Pacheco, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Felipe Melo-González, Daniela Rivera-Perez, Carolina Iturriaga, Marcela Urzúa, Angelica Domínguez, Catalina A. Andrade, Roslye V. Berríos-Rojas, Gisela Canedo-Marroquín, Camila CoviánDaniela Moreno-Tapia, Farides Saavedra, Omar P. Vallejos, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz Venturelli, Carlos M. Perez, Marcela Potin, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Aarón Oyarzún-Arrau, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alessandro Sette, Gang Zeng, Weining Meng, Jose V. González-Aramundiz, Alexis M. Kalergis
Research output: Contribution to journal › Article › peer-review
59Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile'. Together they form a unique fingerprint.